WHO Director-General has arrived in Germany for pivotal high-level meetings focused on strengthening global health security, advancing pandemic preparedness, and fostering stronger international collaboration. Get ready for groundbreaking policies and strategic initiatives to take the spotlight!
Big Pharma’s clinical trials in China are quietly bypassing global oversight, raising urgent alarms about data transparency and ethical practices. This emerging gap poses a serious risk to the trust and integrity of drug approvals worldwide
Argentina has officially announced its withdrawal from the World Health Organization, joining the United States in this surprising decision. This bold step raises urgent questions about the future of global health cooperation at a time when unity is more crucial than ever
Argentina has officially announced its departure from the World Health Organization, sparking widespread concern about the future of global health governance. This daring decision marks a significant shift in the country’s stance on international health policy
Brazil and India have united in a dynamic strategic alliance set to transform cancer drug production. Revealed on TV BRICS, this groundbreaking partnership focuses on pioneering joint research, optimizing manufacturing processes, and guaranteeing affordable access to life-saving treatments for everyone
EXCLUSIVE: Germany is poised to cut funding for its pandemic hub by 50%, marking a significant global retreat from crucial health initiatives. This move raises urgent concerns about our preparedness for both present and future health threats
The World Health Organization (WHO) has proudly honored Brazil for its remarkable achievement in eliminating mother-to-child transmission of HIV, marking a groundbreaking victory in the country’s battle against the virus
The U.S. Department of Health and Human Services and Argentina’s Health Minister joined forces today to unveil an exciting new chapter in their partnership, spotlighting strengthened collaboration on public health initiatives and a united front in the ongoing battle against COVID-19
Exciting news is on the horizon as the U.S. and Argentina prepare to launch a groundbreaking initiative designed to offer a fresh alternative to the World Health Organization (WHO). This innovative approach aims to tackle pressing global health challenges while prioritizing transparency and accountability, responding directly to growing concerns about current systems.
In a daring initiative to tackle soaring healthcare expenses, the US government is setting its sights on pharmaceutical companies, demanding significant reductions in drug prices. At the same time, India’s thriving generics market stands resilient and largely unaffected, prompting intriguing discussions about the shifting landscape of global pricing dynamics.
Recent reports highlight a surge in food poisoning cases across the UK, Bangladesh, Saudi Arabia, India, Japan, Vietnam, and Hong Kong. Health authorities emphasize the importance of food safety regulations and public awareness to combat this global health issue.
Five years after Germany implemented its first COVID-19 lockdown, the nation reflects on the profound societal and economic impacts. From health policies to vaccination campaigns, the pandemic has reshaped public life and informed future crisis response strategies.
Brazil has reported its first case of clade 1b mpox, marking a significant development in public health monitoring. Researchers at the University of Minnesota Twin Cities are closely studying the outbreak to understand its implications and prevent further spread.
Eli Lilly is set to introduce its weight-loss drug in emerging markets this year, aiming to address rising obesity rates. The launch follows successful outcomes in developed regions, positioning Lilly to expand its global footprint in the competitive weight management sector.
Recent studies suggest that scrub typhus, often overlooked in rural India, could impact 1 in 10 individuals, becoming a significant contributor to fever-related hospitalizations. Increased awareness and diagnosis are crucial for improving health outcomes in affected communities.
The India Research Center at Harvard T.H. Chan School of Public Health is spearheading initiatives to address critical health challenges in India. By leveraging interdisciplinary collaborations, the center aims to enhance public health strategies and outcomes across the nation.
